iMedix Medical Content Engine 3.13.37

Hello,

Sign up to join our community!

Welcome Back,

Please sign in to your account!

Forgot Password,

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Sorry, you do not have permission to ask a question, You must login to ask a question.

Neurontin: Uses, dosage, side effects, warnings & patient reviews

Neurontin

Neurontin

Neurontin

Gabapentin
Neurontin is a prescription medication containing the active ingredient gabapentin. It is an anticonvulsant drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of postherpetic neuralgia and as adjunctive therapy for partial onset seizures.
  • ActiveIngredient: Gabapentin
  • DosageForm: Capsules, tablets, and oral solution.
  • Dosage: Capsules: 100 mg, 300 mg, 400 mg. Tablets: 600 mg, 800 mg. Oral solution: 250 mg/5 mL.
  • Indications: Postherpetic neuralgia (PHN); Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy.
  • Manufacturer: Viatris (formerly Pfizer/Parke-Davis)
  • Storage: Store at 25°C (77°F); excursions permitted between 15°C and 30°C (59°F and 86°F).
  • Drug Status: Prescription Only

What is Neurontin (Gabapentin)?

Neurontin is a prescription anticonvulsant medication containing the active ingredient gabapentin. While it is structurally related to the neurotransmitter gamma-aminobutyric acid (GABA), it does not act on GABA receptors. Its precise mechanism of action involves binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, which modulates the release of several excitatory neurotransmitters.

Neurontin is indicated for the management of postherpetic neuralgia (nerve pain following shingles) and as adjunctive (add-on) therapy in the treatment of partial onset seizures in adults and pediatric patients three years and older.

As a medication that affects the nervous system, Neurontin belongs to the broader category of drugs used for pain relief of neuropathic origin. It is excreted unchanged by the kidneys, making dosage adjustment critical in patients with renal impairment.

How to Take Neurontin

Neurontin must be taken exactly as prescribed by a healthcare provider. Dosage is individualized based on the medical condition, kidney function, and response to therapy.

Administration

Neurontin is available as Neurontin capsules, tablets, and an oral solution. Tablets and capsules should be swallowed whole with a full glass of water. The oral solution should be measured with the dosing syringe provided.

To minimize side effects such as dizziness and drowsiness, the initial dose is typically low and gradually increased (titrated) to an effective therapeutic dose over several days or weeks, as directed by a physician.

Important Precautions

  • Do Not Stop Abruptly: Suddenly discontinuing Neurontin can increase the risk of seizures or precipitate withdrawal symptoms. Dose reduction must be gradual and supervised by a doctor.
  • Timing with Antacids: If taking an antacid containing aluminum or magnesium (e.g., Maalox, Mylanta), take Neurontin at least two hours afterward, as antacids can reduce its absorption.
  • Consistency: For consistent blood levels, take the medication at evenly spaced intervals as prescribed, even if you feel well.

Side Effects of Neurontin

All medications have potential side effects. It can be helpful to understand the spectrum of possible side effects.

Common and Serious Side Effects of Neurontin (Gabapentin)
FrequencySide EffectsClinical Notes
Very Common (>10%)Dizziness, drowsiness (somnolence), peripheral edema (swelling of extremities), ataxia (lack of coordination), fatigue.These effects are often dose-related and may diminish over time. Patients should avoid driving or operating machinery until they know how the medication affects them.
Common (1-10%)Nystagmus (involuntary eye movement), tremor, blurred vision, nausea/vomiting, weight gain, dry mouth.Should be reported at the next medical visit. Blurred vision requires caution with activities like driving.
Serious (Seek Medical Help)
  • Signs of an allergic reaction (rash, hives, swelling of the face/lips/tongue, difficulty breathing).
  • Severe dizziness, difficulty walking, or extreme fatigue.
  • Mood or behavior changes, new or worsening depression, anxiety, suicidal thoughts or behavior.
  • Signs of respiratory depression (unusually slow or shallow breathing, extreme sleepiness).
  • Significant swelling in the hands, legs, or feet.
These require immediate medical evaluation. The risk of suicidal thoughts and behavior is a boxed warning for all antiepileptic drugs.

What is Neurontin Used For?

Neurontin (gabapentin) has specific FDA-approved uses and is also prescribed off-label for other conditions under physician supervision.

FDA-Approved Uses

  • Postherpetic Neuralgia: Management of neuropathic pain that follows the healing of acute herpes zoster (shingles).
  • Epilepsy: Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older.

Common Off-Label Uses

Under the direction of a physician, gabapentin may be used off-label for other neuropathic pain conditions. These are not FDA-approved indications but are supported by clinical practice and guidelines.

  • Diabetic peripheral neuropathy.
  • Trigeminal neuralgia and other neuropathic pain syndromes.
  • Restless legs syndrome.
  • Fibromyalgia.

Important: The decision to use Neurontin for an off-label condition involves a physician’s careful assessment of risks and benefits for the individual patient.

Interactions Alcohol:

Unsafe
Concurrent use of alcohol and Neurontin is contraindicated. Alcohol potentiates the central nervous system (CNS) depressant effects of gabapentin, significantly increasing the risk of severe dizziness, drowsiness, impaired judgment, and respiratory depression. This combination also heightens the risk of accidents. For related safety concerns, see information on medications and driving.

Interactions Other Medications:

Consult your doctor
Neurontin has additive CNS depressant effects with other sedating medications. This interaction is particularly dangerous with opioids, increasing the risk of profound sedation, respiratory depression, coma, and death. Concomitant use requires extreme caution and close medical supervision. Other interacting drugs include benzodiazepines, barbiturates, and certain antihistamines like hydroxyzine (Atarax). A comprehensive review of all medications with a prescriber is mandatory.

Special Groups Pregnancy:

Consult your doctor
Data on gabapentin use in pregnancy are limited. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Pregnant patients must have a detailed discussion with their healthcare provider.

Special Groups Breastfeeding:

Consult your doctor
Gabapentin is excreted in human milk. The effects on a nursing infant are unknown. A decision should be made whether to discontinue nursing or discontinue the drug, considering the importance of the drug to the mother.

Special Groups Elderly:

Use with caution
Elderly patients are more likely to have age-related renal impairment, requiring dose adjustment. They are also more sensitive to the CNS effects of gabapentin, leading to a higher risk of dizziness, sedation, and falls. For caregivers, resources are available on managing medications for the elderly.

Special Groups Children:

Safe if prescribed
Neurontin is FDA-approved as adjunctive therapy for partial seizures in children aged 3 years and older. Dosage is based on body weight and must be carefully calculated by a pediatric specialist.

Effects on Activities Driving:

Unsafe
Neurontin causes dizziness and somnolence. Patients should not drive, operate complex machinery, or engage in other hazardous activities until they have sufficient experience with the drug to gauge whether it adversely affects their mental and/or motor performance.

Effects on Activities Operating Machinery:

Unsafe
For the same reasons as driving, operating machinery is considered unsafe, especially during the initial dose titration period and following any dose increase.

Important Safety Concerns and Considerations

Suicidal Behavior and Ideation

Antiepileptic drugs (AEDs), including Neurontin, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication. This risk was observed as early as one week after starting treatment and persisted for the duration of treatment. Patients, their caregivers, and families should be alerted to monitor for the emergence or worsening of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts, behavior, or thoughts about self-harm. Any concerning behaviors should be reported immediately to a healthcare provider.

Respiratory Depression

Serious, life-threatening respiratory depression may occur with Neurontin use. The risk is significantly increased in patients with respiratory compromise (e.g., COPD), elderly patients, and when Neurontin is used concomitantly with other CNS depressants, especially opioids. Symptoms include confusion, extreme drowsiness, diminished responsiveness, and slowed or shallow breathing. This risk underscores the critical danger of combining Neurontin with opioid medications without strict medical oversight.

Dependence and Withdrawal

Physical dependence can develop with Neurontin. Abrupt discontinuation or rapid dose reduction can precipitate a withdrawal syndrome, characterized by anxiety, insomnia, nausea, pain, and sweating. In patients with epilepsy, it may also increase seizure frequency. Discontinuation should be done gradually under medical supervision over a minimum of one week.

Angioedema and Hypersensitivity

Neurontin can cause angioedema, with symptoms such as swelling of the face, mouth (tongue, lips, gums), and throat. Life-threatening respiratory compromise may occur. If angioedema occurs, the drug should be discontinued and emergency medical care sought.

Critical Warnings for Neurontin Use

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

DRESS, also known as multiorgan hypersensitivity, has been reported with antiepileptic drugs. It is a potentially life-threatening condition characterized by fever, rash, lymphadenopathy, and/or facial swelling, accompanied by involvement of other organ systems (e.g., hepatitis, nephritis, hematological abnormalities). The patient should be evaluated immediately if signs or symptoms of DRESS appear, and Neurontin should be discontinued.

Effects on the Nervous System

Neurontin causes dose-dependent effects on the nervous system. Patients should be monitored for signs of CNS depression, including somnolence, sedation, and asthenia. These effects are most prominent during the initiation of therapy or with dose increases.

Use in Patients with Renal Impairment

Gabapentin is eliminated solely by renal excretion. Dosage must be adjusted in patients with compromised renal function, including the elderly, to avoid drug accumulation and toxicity. Guidance on dosage adjustment based on creatinine clearance must be followed precisely. For more on this condition, see information on kidney disease.

Tumorigenic Potential

In standard preclinical in vivo studies, gabapentin was associated with an increased incidence of pancreatic acinar cell tumors in male rats. The clinical significance of this finding is unknown.

Neurontin Dosage Information

Neurontin dosage must be individualized according to the patient’s clinical response, tolerability, and renal function. The following are general guidelines for the two FDA-approved indications. Off-label use follows different dosing protocols determined by a physician.

General Neurontin (Gabapentin) Dosage Guidelines
IndicationRecommended Adult Dosage RegimenKey Considerations
Postherpetic Neuralgia
  • Day 1: 300 mg single dose.
  • Day 2: 300 mg twice daily.
  • Day 3: 300 mg three times daily.
  • Titrate as needed for pain relief up to 1800 mg/day (600 mg TID).
Doses above 1800 mg/day did not show additional benefit in clinical studies. Efficacy is assessed after a stable dose is reached.
Epilepsy (Adjunctive Therapy)
  • Initial: 300 mg three times daily.
  • Maintenance: Dosage may be increased to 900–1800 mg/day in three divided doses, based on response.
  • Maximum dose studied: 3600 mg/day (in divided doses).
Dosage in pediatric patients (3-12 years) is based on body weight (25–40 mg/kg/day). Titration to an effective dose is critical.

Dosage Adjustment in Renal Impairment

For patients with a creatinine clearance (CrCl) less than 60 mL/min, the total daily dose must be reduced and/or the dosing frequency decreased. Physicians use specific tables based on CrCl to calculate the adjusted dose. Patients on hemodialysis require a supplemental dose following each dialysis session.

Important Administration Notes

  • Missed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and resume the regular schedule. Do not double the dose.
  • Discontinuation: When discontinuing Neurontin, taper gradually over a minimum of one week to minimize the risk of withdrawal symptoms or increased seizure frequency.

Drug Interactions with Neurontin

Neurontin has several important pharmacokinetic and pharmacodynamic interactions.

Significant Drug Interactions with Neurontin (Gabapentin)
Interacting SubstanceEffect of InteractionClinical Recommendation
Opioid Analgesics
(e.g., hydrocodone, oxycodone, morphine)
Increased risk of severe and life-threatening CNS and respiratory depression, sedation, dizziness, and death.Concomitant use should be avoided unless absolutely necessary. If used together, the lowest effective doses should be prescribed, and patients must be monitored closely for respiratory depression and sedation.
Other CNS Depressants
(e.g., alcohol, benzodiazepines, barbiturates, sedating antihistamines)
Additive CNS depression, increasing impairment of psychomotor performance, dizziness, and somnolence.Avoid concurrent use. If unavoidable, warn patients of additive effects and advise against driving or hazardous activities.
Antacids containing Aluminum & MagnesiumReduces the bioavailability of gabapentin by approximately 20%.Administer Neurontin at least 2 hours after taking an antacid.
MorphineGabapentin may increase morphine concentrations. Morphine may increase gabapentin concentrations.Monitor for increased CNS and respiratory depression. Dose adjustments may be necessary.

FAQs

Neurontin is the original brand-name product containing gabapentin. Generic gabapentin contains the same active ingredient, in the same strength and dosage form, and is required by the FDA to be bioequivalent. This means it works the same way in the body. For more on this topic, see our article explaining generic medicines.
While not an FDA-approved indication, gabapentin is widely used off-label under physician direction for the treatment of painful diabetic neuropathy. Its use is supported by clinical practice guidelines. Patients with diabetes should discuss comprehensive pain management strategies with their doctor. For related information, see resources on managing diabetes.
Abrupt discontinuation of Neurontin can lead to a withdrawal syndrome, including symptoms like anxiety, insomnia, nausea, pain, and sweating. In patients with epilepsy, it can also precipitate status epilepticus (a prolonged, life-threatening seizure). Therefore, discontinuation must be managed by a healthcare professional through a gradual dose reduction over at least one week.
Neurontin capsules can be opened and the contents mixed with a small amount of soft food (e.g., applesauce, pudding) for patients who have difficulty swallowing. The entire contents must be consumed immediately; the mixture should not be stored. Neurontin tablets are scored and may be split in half along the score line if a lower dose is needed. Do not crush the tablets.
Store Neurontin capsules and tablets at room temperature, 20°C to 25°C (68°F to 77°F), in a tightly closed container. Protect from moisture. Keep out of reach of children and pets. Do not use after the expiration date on the bottle.

Additional Information

Storage and Handling

Store Neurontin capsules, tablets, and oral solution at controlled room temperature between 20°C to 25°C (68°F to 77°F). The oral solution should be stored in an upright position. Keep all medications in their original container, tightly closed, and out of the reach of children and pets. Safely discard any unused or expired medication.

Cost and Generic Availability

Generic gabapentin is widely available and is typically significantly less expensive than the brand-name Neurontin. The Neurontin price for the brand product is higher. Patients seeking Neurontin online should exercise extreme caution and only use licensed, reputable pharmacies that require a valid prescription to avoid counterfeit products.

Reporting Side Effects

Patients and caregivers are encouraged to report negative side effects of prescription drugs to the U.S. Food and Drug Administration (FDA) via the MedWatch program at 1-800-FDA-1088 or online at www.fda.gov/medwatch. Reporting helps the FDA monitor drug safety.

References and Medical Sources

  1. U.S. Food and Drug Administration (FDA). Neurontin (gabapentin) Prescribing Information. [Revised 2017]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf
  2. MedlinePlus. Gabapentin. U.S. National Library of Medicine. [Updated 2022]. https://medlineplus.gov/druginfo/meds/a694007.html
  3. American Epilepsy Society. Guideline for the Treatment of Adults with Epilepsy. [Updated 2022].
  4. Finnerup, N. B., et al. “Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.” The Lancet Neurology, 2015.

You must login to add a comment.

Popular Questions

Top Members

Join the discussion

Comments are published after moderation. User opinions do not constitute medical advice.

We sincerely appreciate you taking the time to share your feedback. Every user's perspective is valuable to us.

Ask to get answers.